Acumen Pharmaceuticals Inc (ABOS) — Financial Flexibility Index
Acumen Pharmaceuticals Inc (ABOS) has a Financial Flexibility Index of -0.52x as of March 2026. Free cash flow of $-24.13 Million (operating CF $-24.13 Million minus capex $0.00) represents -1% of total liabilities ($46.15 Million). Check Acumen Pharmaceuticals Inc (ABOS) tangible equity ratio to evaluate the tangible quality of the company's equity base.
Financial Flexibility Index
Free Cash Flow
Total Liabilities
Capital Expenditures
Acumen Pharmaceuticals Inc Financial Flexibility Index (2019–2025)
Historical Financial Flexibility Index trend for Acumen Pharmaceuticals Inc across 7 annual periods. For the full cash flow conversion analysis, see Acumen Pharmaceuticals Inc (ABOS) cash conversion ratio.
Annual Financial Flexibility Index for Acumen Pharmaceuticals Inc (2019–2025)
Year-by-year free cash flow to debt coverage for Acumen Pharmaceuticals Inc. Explore ABOS cash flow to debt ratio to assess how comfortably operating cash covers total debt obligations.
| Year | Flexibility Index | Free Cash Flow (USD) | Operating CF | Total Liabilities | YoY Change |
|---|---|---|---|---|---|
| 2025 | -2.20x | $-115.45 Million | $-115.54 Million | $52.40 Million | ▼ -46.1% |
| 2024 | -1.51x | $-86.20 Million | $-86.22 Million | $57.18 Million | ▼ -51.1% |
| 2023 | -1.00x | $-43.04 Million | $-43.06 Million | $43.15 Million | ▲ +77.7% |
| 2022 | -4.48x | $-34.99 Million | $-35.15 Million | $7.81 Million | ▼ -28.6% |
| 2021 | -3.48x | $-17.92 Million | $-17.96 Million | $5.15 Million | ▼ -2861.2% |
| 2020 | -0.12x | $-7.41 Million | $-7.45 Million | $63.02 Million | ▲ +67.5% |
| 2019 | -0.36x | $-6.78 Million | $-6.82 Million | $18.74 Million | — |